Source:http://linkedlifedata.com/resource/lhgdn/association:125
| Predicate | Object |
|---|---|
| lhgdn:found_in | |
| lhgdn:geneRifSource |
the 4 biomarkers CLU, ITGB3, PRAME and CAPG may be used as prognostic factors for patients with stage III serous ovarian adenocarcinomas.
|
| lhgdn:mesh_code |
D000230
|
| lhgdn:associationIdType | |
| lhgdn:umls_code |